{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:28:23Z","timestamp":1759332503942},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.transproceed.2005.06.104","type":"journal-article","created":{"date-parts":[[2005,9,23]],"date-time":"2005-09-23T13:48:14Z","timestamp":1127483294000},"page":"2675-2678","source":"Crossref","is-referenced-by-count":16,"title":["New Strategies in Immunosuppression"],"prefix":"10.1016","volume":"37","author":[{"given":"M.B.","family":"Regazzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alessiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2005.06.104_bib1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(03)13175-3","article-title":"Tolerogenic immunosuppression for organ transplantation","volume":"361","author":"Starzl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2005.06.104_bib2","unstructured":"2003 OPTN\/SRTR Annual Report 1993-2002: HHS\/HRSA\/SPB\/DOT; UNOS; URREA"},{"key":"10.1016\/j.transproceed.2005.06.104_bib3","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/ndt\/17.12.2051","article-title":"Tailoring immunosuppressive therapy","volume":"17","author":"Kuypers","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00007691-200406000-00003","article-title":"Monitoring immunosuppressive drugs","volume":"26","author":"Holt","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2005.06.104_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00129785-200303050-00001","article-title":"The pharmacogenetics of immunosuppression for organ transplantation","volume":"3","author":"Fredericks","year":"2003","journal-title":"Am J Pharmacogenomics"},{"key":"10.1016\/j.transproceed.2005.06.104_bib6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/01.ASN.0000073901.94759.36","article-title":"Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients","volume":"14","author":"Anglicheau","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2005.06.104_bib7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1600-6143.2004.00537.x","article-title":"Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients","volume":"4","author":"Vlaminck","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7182\/prtr.10.4.86x83x21676t1883","article-title":"Personality disorders","volume":"10","author":"Dobbels","year":"2000","journal-title":"Prog Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7182\/prtr.11.2.c11554106212t7p1","article-title":"Psychosocial and behavioral selection criteria for solid organ transplantation","volume":"11","author":"Dobbels","year":"2001","journal-title":"Prog Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib10","doi-asserted-by":"crossref","first-page":"s88","DOI":"10.1097\/01.TP.0000126934.97815.2E","article-title":"New drugs to improve transplant outcomes","volume":"77","author":"First","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.06.104_bib11","doi-asserted-by":"crossref","first-page":"O364","DOI":"10.1097\/00007890-200407271-00377","article-title":"Conversion of stable kidney transplant recipients from a twice daily Prograf based regimen to a once daily modified release tacrolimus based regimen","volume":"78","author":"Alloway","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.06.104_bib12","doi-asserted-by":"crossref","first-page":"O305","DOI":"10.1097\/00007890-200407271-00318","article-title":"Conversion of stable liver transplant recipients from a twice daily Prograf based regimen to a once daily modified release tacrolimus based regimen","volume":"78","author":"Florman","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.06.104_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation","volume":"43","author":"Staatz","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.transproceed.2005.06.104_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00007890-200407271-00423","article-title":"The advantage of tacrolimus versus ciclosporin-based therapy after heart transplantation\u2014a large European phase III study","volume":"78","author":"Yonan","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.06.104_bib15","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.healun.2003.11.013","article-title":"Risk\/benefit evaluation of Tacrolimus (TAC) vs cyclosporine microemulsion (CsA) after cardiac transplantation","volume":"23","author":"Rinaldi","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/ndt\/gfg555","article-title":"Monoclonal antibodies in renal transplantation","volume":"19","author":"Kuypers","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib17","doi-asserted-by":"crossref","first-page":"O432","DOI":"10.1097\/00007890-200407271-00445","article-title":"A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine","volume":"78","author":"Ponticelli","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.06.104_bib18","doi-asserted-by":"crossref","first-page":"O430","DOI":"10.1097\/00007890-200407271-00443","article-title":"A multicenter, open label pilot study of early (5 day) corticosteroids cessation in de novo renal transplant recipients under simulect, tacrolimus, and sirolimus therapy","volume":"78","author":"Woodle","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.06.104_bib19","doi-asserted-by":"crossref","first-page":"O431","DOI":"10.1097\/00007890-200407271-00444","article-title":"Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor (CNI) and mycophenolate mofetil (MMF) and triple regimen consisting of CNI, MMF and steroid","volume":"78","author":"Teraoka","year":"2004","journal-title":"Transplantation"},{"issue":"suppl 5","key":"10.1016\/j.transproceed.2005.06.104_bib20","first-page":"200","article-title":"Immunosuppressive monotherapy after kidney transplantation comparison between tacrolimus and cyclosporine-microemulsion","volume":"3","author":"Short","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib21","doi-asserted-by":"crossref","first-page":"O429","DOI":"10.1097\/00007890-200407271-00442","article-title":"Steroid-free immunosuppression with daclizumab, tacrolimus and MMF is efficacious and improves cholesterol, glucose and bone mineral density\u2014The CARMEN study","volume":"78","author":"Budde","year":"2004","journal-title":"Transplantation"},{"issue":"suppl 4","key":"10.1016\/j.transproceed.2005.06.104_bib22","first-page":"788","article-title":"Large prospective study evaluating steroid-free immunosuppression with tacrolimus\/basiliximab and tacrolimus\/mmf compared with tacrolimus\/mmf\/steroids in renal transplantation","volume":"18","author":"Klinger","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/lt.20307","article-title":"Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab","volume":"1","author":"Boillot","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2005.06.104_bib24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1034\/j.1600-6143.2002.21005.x","article-title":"What\u2019s in the pipeline? New immunosuppressive drugs in transplantation","volume":"2","author":"Vincenti","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.TP.0000132563.08111.88","article-title":"FK778","volume":"78","author":"Fawcett","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.06.104_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/01.TP.0000076382.87978.73","article-title":"Leflunomide analogue FK778 is vasculo-protective independent of its immunosuppressive effect","volume":"76","author":"Savikko","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.06.104_bib27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/01.TP.0000063704.19149.E3","article-title":"FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts","volume":"75","author":"Pan","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.06.104_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000441-199705000-00008","article-title":"Leflunomide and malononitrilamides","volume":"313","author":"Silva","year":"1997","journal-title":"Am J Med Science"},{"key":"10.1016\/j.transproceed.2005.06.104_bib29","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00007890-199909270-00014","article-title":"F. Novel mechanism of inhibition of human cytomegalovirus by the experimental immunosuppressive agent, leflunomide","volume":"68","author":"Waldman","year":"1999","journal-title":"Transplantation"},{"issue":"suppl 5","key":"10.1016\/j.transproceed.2005.06.104_bib30","first-page":"942","article-title":"Cytomegalovirus (CMV) antiviral activity of the malanonitrilamide FK778","volume":"3","author":"Zeng","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.06.104_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.TP.0000132562.54089.62","article-title":"The effect of KF778 in combination with Tacrolimus and steroid","volume":"78","author":"Vanrenterghem","year":"2004","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505007402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505007402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T04:50:18Z","timestamp":1548132618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134505007402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0041134505007402"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2005.06.104","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}